Olivier Delporte is an international executive with 20 years of sales, marketing and general management experiences, mostly in the medical devices industry.
Prior to Joining Miracor, he was Senior Vice President, Sales & Marketing, OUS at PneumRx (acquired by BTG in 2015) and, prior to that, the commercial operations of Tryton Medical in Europe, Middle East and Africa, as Vice President of Sales and marketing. Prior to Tryton Medical Management at Guidant and Abbott Vascular. Olivier has studied and worked in the US, France, Spain, and Belgium. He is a director of Endotoxins Therapeutics.
Olivier earned a Masters Degree in Business from the Université Catholique de Louvain, Belgium, and an MBA from the University of Chicago.
(*) represented by ODMC bvba, a management company
Vice President Regulatory, QA & US Operations
Kimberlie has more than 20 years of experience with a focus on cardiovascular therapies. She has held leadership roles in clinical, regulatory and quality for early stage, mid-stage and large organizations.
Prior to joining Miracor, Kim was Vice President of Clinical, Regulatory & Quality for Mitralign, Inc. where she was responsible for all clinical programs, achieving CE Mark and US Early Feasibility approvals for their mitral and tricuspid valve repair therapy. Kim’s experience also includes 13 years with Medtronic where she held several roles in the Regulatory and Clinical Affairs organizations for the Coronary and Endovascular Therapies businesses.
Kim received a Bachelor of Science degree in Biotechnology from Worcester Polytechnic Institute, a Master’s degree in Regulatory Affairs & Health Policy from Massachusetts College of Pharmacy and MBA from the Van Loan School of Management at Endicott College.
Vice President Clinical Affairs, Europe
Jozef has more than 15 years of experience in the pharmaceutical and medical device industry in clinical development across all phases for various IMPs, ATMPs and medical devices focus on early and translational medicine in cardiology, pulmonology, organ transplantation and regenerative medicine as well as several years of experience in animal research.
Before joining Miracor, Jozef was Director Medical Affairs and prior to that Director Clinical Affairs at PneumRx BTG where he where he played a key global role supporting clinical development and therapy adoption. Earlier in his career, Jozef worked with Xeltis developing an autologous pulmonary valve and cardiovascular conduits as well as with Roche and Astellas conducting clinical studies on various pharmaceutical products.
Jozef holds a MSc degree in Biochemistry and Physiology at the Comenius University in Bratislava, Slovak Republic, and work as research fellow at Slovak Academy of Science conducting animal research on ischemic precondition and myocardial regenerative pathways.
Dr. Ir. Ventzeslav Iordanov
Sr. Director R&D
Ventzeslav Iordanov has 18 years of experience in the field of system architecture, of which more than 12 years in the medical device products industry. In that time, he led multinational teams in the process of design and development of more that 15 demonstrators and prototypes, and 3 commercial products.
Before joining Miracor, Ventzeslav was Director R&D Medimetrics Personalized Drug Delivery B.V. where he has been responsible for the development and transfers to manufacturing of drug-device combination products. In parallel, he also has led the QA&RA team in defining a Quality Management System (fully compliant to the EU and US regulations) for the support of design, certification and commercialization of medical device products.
Ventzeslav received an Engineer Diploma in Applied Physics from the Sofia University (Bulgaria) a Master’s degree in Electronics from the Sofia University and the Delft University of Technology (The Netherlands) and he holds a PhD in Electronic Instrumentation from the Delft University of Technology.